Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Abiraterone Acetate Affects Gene Expression Profile in a Human Male Neuronal Cell Line: Potential Mechanism for Cognitive Deficits with Prostate Cancer Therapy.
Journal: Life (Basel, Switzerland)
Published: June 12, 2026
ARAMON, a phase 2 open-label trial of darolutamide monotherapy in patients with biochemical recurrence or oligometastatic castration-sensitive prostate cancer after radical prostatectomy or primary radiotherapy.
Journal: European urology focus
Published: February 27, 2026
Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment in Metastatic Urothelial Cancer: A Randomized Phase II Study of Two Alternative Dosing Schedules.
Journal: Clinical genitourinary cancer
Published: February 11, 2026
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma.
Journal: ESMO open
Published: April 03, 2025
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].
Journal: European urology
Published: October 19, 2024
A Phase 1, Open-label, Dose-Ascending Study to Evaluate the Safety and Tolerability of the Therapeutic Radiopharmaceutical 131I-MIP-1095 for the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical nuclear medicine
Published: October 09, 2023
Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 17, 2022
Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes.
Journal: Cancer medicine
Published: December 03, 2020
A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research.
Journal: OncoTargets and therapy
Published: November 04, 2020
Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg?
Journal: Current opinion in urology
Published: August 22, 2017
Increase in Cancer Center Staff Effort Related to Electronic Patient Portal Use.
Journal: Journal of oncology practice
Published: September 08, 2016
Last Updated: 09/26/2026